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Abstract
Background: Patient-centered care recognizes the obligation to understand and meet patient’s expectations. An
individual’s satisfaction has been found to affect health-related decisions and treatment-related behaviours, which
in turn affect medical compliance, follow-up, the success of treatment and the appropriate use of services. We
studied the expectations, experiences and satisfaction of patients who participated in clinical trials for retinal
diseases at the Sydney Eye Hospital.
Methods: The study was undertaken at the research clinic of the major public quaternary eye hospital in New
South Wales, Australia. A 37-question survey was conducted on patients enrolled in or who had finished a clinical
trial for macular disease in the 12 months preceding this study in November 2012. Patient satisfaction was assessed
using close-ended, multiple choice questions. First, the decision making process for entering into the clinical trial
was evaluated. Then the level of patient understanding and experience during the study was assessed. Finally, there
was a series of questions to gauge the participants’ perception of trial outcomes and overall impression gained
from the experience.
Results: Eighty patients completed the questionnaire. Overall patient satisfaction was high with the majority of
patients stating they would recommend participation in a retinal clinical trial (94 %) and participate in a subsequent
trial (78 %). Most patients rated themselves as the most important factor in making the decision to join a trial.
Patients felt well informed and expectations were generally felt to be met, however 14 % did not believe that they
could withdraw from the study voluntarily. The most common reasons for trial participation were to contribute to
medical science and to have improved treatment outcomes.
Conclusions: We found that patients generally found participation in retinal clinical trials to be a positive
experience. Factors contributing to dissatisfaction mainly related to inconvenience experienced by transportation
and waiting times. We also found that patients felt well informed about the study, but some did not have a
complete understanding of their rights, which had been communicated to them when they entered the study.
There were both altruistic and self-motivated reasons behind patients’ decisions to join a retinal trial.
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Background
Clinical trials are considered the ‘gold standard’ by
which clinicians decide if treatments are safe and effect-
ive. Patient satisfaction, defined as the fulfilment of ex-
pectations and needs, incorporates patients’ perceptions
and preferences when evaluating the success of medical
treatments and healthcare delivery systems [1–3].
Moreover, an individual’s satisfaction has been found to
affect health-related decisions and treatment related be-
haviors, which in turn affect medical compliance, follow-
up, the success of treatment and the appropriate use of
service [4–7]. Previous surveys suggest that patients
positively view their experience of ophthalmology clinics
[8–12]. Patient satisfaction has been linked to participa-
tion in decision-making, clinicians’ communicative be-
havior, treatment outcome and patients’ expectations
regarding psychosocial support as well as therapeutic lis-
tening [13–20]. However, this has not been examined
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specifically in the context of retinal clinical trials, which
may be more labour intensive than interventions for
other medical conditions.
The objective of our study was to understand what
motivated patients to participate in clinical trials for ret-
inal disease, and to determine if the experience was a
satisfactory one. This is important, as patient satisfaction
is linked to patient compliance with therapy [21, 22],
which is necessary for optimal long term outcomes, as
well as increased number of hospital recommendations
by patients to others and improved reputation [23, 24]
We anticipated that the information gained from this
study might identify ways to improve the clinical trial
process and aid in patient recruitment. Information
gathered about level of understanding and decision-




This was a cross-sectional study of all patients currently
enrolled in, and those who had completed clinical trials
for retinal disease in the preceding 12 months at the
start of the study in November 2012, in the Macular
Research clinics at the Sydney Eye Hospital. The Sydney
Eye Hospital is a quaternary referral unit located within
the Central Business District of Sydney. Participants
were available from 14 retinal clinical trials. Eighty con-
secutive patients who were attending the research clinics
were recruited for this exploratory, non-comparative
study.
Ethics
The study was approved by the Human Research Ethics
Committees of Royal Prince Alfred Hospital (LNR/12/
RPAH/382). Patients read the participant consent form
and verbal consent was obtained by the research staff.
Participation was voluntary.
Survey administration
Research staff identified eligible patients upon their
arrival at the clinic and gave them an information sheet
on the study along with the questionnaire. The surveys
were either self completed or were completed with the
help of an accompanying friend, family member or inter-
preter. Large font versions of the questionnaire were
available for those who were visually impaired. The sur-
vey was filled out anonymously with only generic demo-
graphic data collected. Patients returned their completed
surveys to a sealed box in the clinic area.
Data analysis
The survey format consisted of a 37 item questionnaire
(Additional file 1). Questions were formulated by the
authors of the present study after a literature review of
previous surveys [8–20], and after discussion with
medical, nursing and paramedical staff, to ensure face
validity. The questions were chosen to represent a wide
range of areas of concern that might affect patient satis-
faction in retinal clinical trials. The development of this
questionnaire was guided by the evidence base for selec-
tion of rating scales [25–27]. Rating scales had a simple
question format, with categories that included frequency,
severity and global ratings. These rating scale categories
were presented in a clear progression and were concep-
tually exhaustive, using a Likert scale to scale responses
allowing for one response [28, 29]. For the small number
of questions that allowed for multiple responses, the per-
centage of each response was calculated by dividing the
total number of each response by 80. Responses left
blank were censored as missing data.
Results
Description of the clinical trials
Participants in 14 retinal clinical trials were eligible for
the study. Most of the retinal clinical trials compared
the outcomes of two different drugs, although some
compared the effect of a drug versus a placebo. A full
description of each trial is provided in Additional file 2.
The survey was completed by 96 % of the eligible sub-
jects approached. Of the three patients who declined the
survey, two could not read English and one had poor vi-
sion and did not have an accompanying carer. Of the 80
participants, approximately half (53 %) were male, with
the median age within the 61 and 70 age selection range.
Half the patients surveyed (51 %) were born outside
Australia and English was a second language for 30 % of
participants. Approximately a third (36 %) of the 80 par-
ticipants had been in a previous retinal trial at the
Sydney Eye Hospital.
Decision-making process and entry into the trial
The majority of patients (88 %) stated that their main
source of information for entering the trial was from
medical staff (doctors and nurses), and 96 % of patients
thought they received adequate information about the
trial. More than half of the patients (55 %) stated that
they themselves were the most influential in their deci-
sions to join the trial, while 30 % thought that doctors
were the most influential. Most patients (84 %) made
their decisions to participate within one day.
Reasons for participating in the trial varied, but the
two most popular responses were that participants
‘wanted to contribute to medical science’ and they
wanted their ‘eyes to be more closely monitored’ (Fig. 1).
None of the participants felt they had been pressured to
join or were unable to ascribe a reason for joining. A
total of 246 responses were obtained for this question.
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Perceived benefits and problems with trial participation
Patients were also allowed multiple responses when de-
scribing perceived benefits of trial participation. The ma-
jority of patients (76 %) stated the goal of participation
within their particular clinical trial was to improve med-
ical care for future patients, half (50 %) described partici-
pation was to benefit themselves and a third (35 %) also
felt that the goal was to give doctors experience with a
new drug. Ninety percent of patients agreed that the trial
provided important information to medical science. The
vast majority of patients (95 %) agreed that staff kept
them up to date on the study progress.
When asked about problems with trial participation, a
sizeable minority of patients (24 %) thought too much
time was spent at the clinic. Other problems highlighted
included transport difficulties (13 %), parking problems
(8 %), unclear directions to the appointment location
(3 %), difficulty getting off work for appointments (3 %)
and changes of clinical staff (1 %). Fourteen percent of
patients thought they could not withdraw from the trial,
which was incorrect. The majority of patients did not
think there were too many follow up visits (74 %) or
forms to complete (78 %).
Trial outcomes
Subjective outcomes of participation in the clinical trials
were generally positive, as outlined in Table 1. Sixty
Fig. 1 Reasons for joining a retinal clinical trial at the Sydney Eye Hospital
Table 1 Trial outcomes from the patients’ perspectives
Question Response n (%)
How did you benefit from
participating in the trial?




Free medical care and
services
35 (44 %)








Other 5 (6 %)
How have you felt since
having the treatment?
Much better 32 (40 %)
Somewhat better 18 (23 %)
About the same 15 (19 %)
Somewhat worse 3 (4 %)
Much worse 0 (0 %)
Have you experienced any
side effects from the treatment?
Yesb 11 (14 %)
No 50 (63 %)
Unsure 5 (6 %)
aRemediation refers to correction of visual health as defined by the specific
retinal trial
bSide effects listed by patients included pain, increased appetite, hair hanging
in eye, headaches, cataract, blurred vision, smell, burning and gritty sensation
in eye, small tingles in eye, and glaucoma
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three percent of participants stated that they felt much
or somewhat better as a result of participating in the
study while only 4 % felt somewhat worse.
Relationship with medical staff
Overall, patients had a positive impression of medical
staff: 93 % thought staff always treated them with cour-
tesy and respect and 96 % thought staff were always
helpful. From the patient’s perspective, clinical staff
always (86 %) or usually (9 %) worked well together as a
team. Seventy six percent of patients always felt valued
and appreciated as a patient, while a further 15 %
thought that this was the case usually. Eighty six percent
of patients never had any doubts about the ability of
their treating doctors, although 6 % sometimes had
doubts and 2 % usually had doubts. However, no patient
always had doubts about their doctors’ abilities. Since
enrolment in a clinical trial, the patient’s relationship
with their doctor improved in over half (58 %) of cases,
in 38 % the relationship remained unchanged and no
patient described trial participation worsening their rela-
tionship with the treating medical team.
Overall patient impression of the clinical trial
Table 2 outlines patients’ overall impression of their clin-
ical trials, which was mostly positive. The overwhelming
majority of patients felt that taking part in the trial was
important for their condition and would recommend
participation to another person.
Discussion
Increasingly, participant experience studies are under-
taken as part of clinical trials to improve recruitment, as
well as the delivery and conduct of future trials [30].
Most of these studies, not in the field of ophthalmology,
have focused on patients’ understandings and experi-
ences and how these might influence recruitment, re-
tention and adherence to the investigated intervention
[31–34]. Ophthalmology patient satisfaction studies
have mainly been in the areas of cataract and refractive
surgeries [8–11], as well as in for oculoplastics and
glaucoma surgeries [12, 35]. Our study provides insight
into patient experiences and satisfaction in clinical trials
in the context of translational retinal research.
In this study we surveyed 80 consecutive patients par-
ticipating in various clinical trials for retinal diseases.
We found that participants generally found their experi-
ence in retinal clinical trials to be positive and satisfying.
These findings are reassuringly consistent with other
studies of patient satisfaction within the clinical trial en-
vironment in ophthalmology as well as other fields of
medicine [9, 13–15, 32, 33].
Recruiting and maintaining participants in clinical tri-
als is vital and often challenging. In order to achieve
good trial recruitment and retention, an understanding
of what makes the experience satisfactory for the patient
is likely to be helpful. To address this need, our study in-
vestigated the reasons for trial participation, expectations
and measures of satisfaction. In a study including inpa-
tients and outpatients after cataract surgery from three
facilities, Nijkamp et al. found that satisfaction with regard
to the quality of care, judgments about the counseling,
and meeting patients’ preoperative expectation concerning
the medical outcome were predictors of overall patient
satisfaction [14]. Predictors were consistent among the in-
vestigated settings and overall satisfaction scores also did
not significantly differ. Jackson et al. also reported that
understanding and meeting initial expectations is an im-
portant component of achieving a satisfactory patient ex-
perience in a general medicine walk-in clinic [36].
We examined the decision making process to enter
clinical trials of retinal disease in terms of patient
Table 2 Overall impression of the retinal clinical trial
Question Response n (%)
How important do you feel taking part
in this trial is to your condition?
Very important 68 (85 %)
Fairly important 5 (6.25 %)
Slightly important 3 (3.75 %)
Not at all important 2 (2.5 %)
Missing data 2 (2.5 %)
Would you recommend participation
in this trial?
Yes 75 (93.75 %)
No 2 (2.5 %)
Unsure 2 (2.5 %)
Missing data 1 (1.25 %)
Volunteer for another trial? Yes 62 (77.5 %)
No 3 (3.75 %)
Unsure 14 (17.5 %)
My expectations of joining the trial were Met 50 (62.5 %)
Somewhat met 18 (22.5 %)
Somewhat unmet 2 (2.5 %)
Unmet 2 (2.5 %)
Unsure 3 (3.75 %)
Missing data 5 (6.25 %)
How would you rate the overall quality
of care and services provided in the
clinical trial?
Excellent 59 (73.75 %)
Good 16 (20 %)
Fair 1 (1.25 %)
Poor 0 (0 %)
Missing data 4 (5 %)
Would you return to the Sydney Eye
Hospital should the need arise?
Yes 73 (91.25 %)
No 0 (0 %)
Unsure 4 (5 %)
Missing data 3 (3.75 %)
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understanding and reasoning. We found that the pri-
mary source of trial information came from medical
staff, with the majority of patients (96 %) feeling that ad-
equate information had been given to them. This em-
phasises that ophthalmologists and other clinical staff
have an important role to increase patient participation
in trials, since they are by far the primary source of in-
formation about the study. However, most patients rated
themselves as the most important factor in making the
decision, with the decision usually made within 24 h;
this emphasizes that recruitment in clinical trials should
be patient-focussed with the amount and level of infor-
mation geared appropriately towards patients.
It is noted that 14 % of patients did not feel they could
withdraw from the study. This is an inaccurate perception
which demonstrates the potential for misunderstanding in
the consent process, possibly resulting from language bar-
riers and the use of lengthy consent documentation. Par-
ticipants might have been more focused on the actual
treatment and side effects or visit scheduling information
and the decision making of whether to enter a clinical
trial, and less on other issues such as withdrawing. The
conduct of verbal consent, the conduct of the survey on
site, and the signing of the consent for retinal studies
all in one day may all be unintentional subtle sources
of undue influence. Nevertheless, this highlights the im-
portance of clearly explaining to patients their rights
when entering the study as well as their obligations,
and not ‘flooding’ patients with too much information
simultaneously.
We found that there were both strong altruistic and
self-motivated reasons behind patients’ decision to par-
ticipate in trials. The most popular responses as to why
they participated in a clinical trial were ‘to assist medical
science’ and ‘to have (their) condition more closely
monitored’. These findings were corroborated by mea-
sures for patient satisfaction, with the most common
benefit described by patients as increased knowledge of
their particular medical condition. Other popular re-
sponses were free medical care and services and in-
creased contact with the treating team.
Consistent with other studies, there appears to be a
desire amongst a significant proportion of patients to
feel actively involved in their care, expressed by a desire
for greater knowledge and greater contact with staff
[37]. This increased involvement can lead to improved
patient outcomes as well as satisfaction. It is acknowl-
edged that those who had volunteered for trials were
more likely to have this desire for participation. In terms
of advocating trial involvement, it can be seen from our
study that those who joined largely described a desire
for a greater sense of knowledge, involvement and fre-
quency of care, and that expectations were largely satis-
fied through the trial process.
Another aspect of assessing participant satisfaction
was the patient response to services and caregivers. We
found that the vast majority of patients within the retinal
research clinics studies were very satisfied with services
and staff, with 74 % rating them as ‘excellent’. Previous
studies have consistently demonstrated the importance
of communication between patients and their caregivers
and the value of providing relevant information such
as regarding operative processes or diagnostic tests
[16, 38–43]. Our study corroborated these findings, with
patient interaction with staff likely playing an important
role in achieving overall high satisfaction. The impact of
study participation on relationship with staff was also
demonstrated by the fact that 58 % of patients thought
their relationship with their doctors improved through
participating in the clinical trial. Further qualitative re-
search may be warranted to elucidate the specific im-
portant aspects of this relationship with patients. A
qualitative study using focus groups by Dawn et al. iden-
tified 6 areas of expectations for eye care that were im-
portant to patients: honesty, information about diagnosis
and prognosis, explanation in clear language, ophthal-
mologists’ experience and reputation, empathy and lis-
tening and addressing concerns [19].
We also sought to identify areas of dissatisfaction in
order to understand if these could be addressed to im-
prove the patient experience and whether these elements
of dissatisfaction were related to the trial experience.
The main problem identified was prolonged wait time in
the clinic, transport and parking problems. Communica-
tion and information provision to health consumers, es-
pecially in relation to waiting times, have been shown to
have positive effects on satisfaction levels, resulting in
significant falls in complaint levels [44]. A discussion
and briefing regarding wait times is indeed performed
with patients in the clinics studied. While wait times
remain a source of discontent, it is possible that the
communication that takes place around these times mit-
igates their impact on overall patient satisfaction,
reflected in the fact that 93 % of patients remained will-
ing to return to the public outpatient clinics at the con-
clusion of the study. Further, patients did not feel their
time was being generally wasted, as three-quarters of
them did not think there were too many follow up visits
or that there were too many forms to complete. The lat-
ter may be because data collection was predominantly
performed by study staff rather than patients. There
were very few studies that asked patients to complete
forms.
Access to the clinic was a major cause of patient dis-
satisfaction. Since the hospital is a quaternary referral
service, as is likely to be the case for other centres where
clinical trials of retinal disease are performed, patients
usually were not travelling from the immediate locality.
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Sponsored clinical trials would have the means to pro-
vide adequate reimbursement for travel and parking to
the investigational site, but this may not be feasible for
investigator initiated trials.
The major limitations of this study are those inherent
in cross-sectional, ‘self-reporting’ questionnaire surveys.
Patients who are more satisfied with care are less
likely to return questionnaires, thus potentially under-
estimating satisfaction levels [45]. Despite this, the re-
sponse rate of our survey was high at 96 %, with those
few declining mainly citing language difficulties. Never-
theless, we could not assess the differences in baseline or
clinical characteristics between the responders and non-
responders. Furthermore, there was the potential undue
influence of patients being handed the survey by research
staff and the expectation to complete it on site. A lower
response rate might have been attained if the survey was
not allowed to be completed on site, however this ap-
proach would cause greater inconvenience to patients
and would yield a much lower response rate. Another
limitation of this study was that the distribution of pa-
tients across the 14 retinal trials was not known, as we
did not collect this information from the questionnaire.
We confirmed that they were from at least one of the
listed studies only. Our population was a consecutive
sample and included patients from a number of different
trials. Our clinics are not differentiated based on which
clinical trials the patients are part of.
Tendency for respondents to bias towards positive re-
sponses and use acquiescent replies was minimized by
adopting positively or negatively worded, specific ques-
tions [25, 46, 47]. However, one question was con-
structed with a positive bias: “How did you benefit from
participating in the study?” This question did not offer a
neutral or negative response option, and thus it was un-
surprising that a high majority of respondents described
this study as beneficial. This could have been avoided if
a more vigorous question selection process had been
undertaken, that would include multiple pilot tests,
focus groups and interviews to enhance content validity
[48, 49]. Other questions appropriately included the full
range of response options. In addition, while the specific
and limited range of responses allowable assisted in giv-
ing a good overview of quantifiable data, further qualita-
tive research would likely be of benefit to explore
further patient views and level of understanding. It is
conceded that if we had studied patients who were
approached for participation in clinical trials rather than
those who had already consented to join, we may well
have found different responses to some questions.
Conclusions
Patient satisfaction is of fundamental importance as a
measure of the quality of care because it gives information
on the providers’ success at meeting health consumers’
values and expectations. The results of this study indicate
that most patients were satisfied with their experiences
and outcomes from participating in a retinal clinical trial
at the Sydney Eye Hospital, despite dissatisfaction with
some aspects of the clinical trial process and a small
percentage of patients experiencing some side effects.
Gaining a better understanding of patients’ expectations
in ophthalmic clinical trials may help better guide efforts
to educate patients, to reduce unreasonable expectations
and, ultimately, to improve their experience.
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